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OBJECTIVES: Delay in the treatment of pleural infection may contribute to its high mortality. In this retrospective
study, we aimed to evaluate the diagnostic accuracy of pleural adenosine deaminase in discrimination between
Gram-negative and Gram-positive bacterial infections of the pleural space prior to selecting antibiotics.
METHODS: A total of 76 patients were enrolled and grouped into subgroups according to Gram staining:
1) patients with Gram-negative bacterial infections, aged 53.2±18.6 years old, of whom 44.7% had empyemas
and 2) patients with Gram-positive bacterial infections, aged 53.5±21.5 years old, of whom 63.1% had
empyemas. The pleural effusion was sampled by thoracocentesis and then sent for adenosine deaminase
testing, biochemical testing and microbiological culture. The Mann-Whitney U test was used to examine the
differences in adenosine deaminase levels between the groups. Correlations between adenosine deaminase
and specified variables were also quantified using Spearman’s correlation coefficient. Moreover, receiver
operator characteristic analysis was performed to evaluate the diagnostic accuracy of pleural effusion adenosine
deaminase.
RESULTS: Mean pleural adenosine deaminase levels differed significantly between Gram-negative and Gram-
positive bacterial infections of the pleural space (191.8±32.1 U/L vs 81.0±16.9 U/L, po0.01). The area under the
receiver operator characteristic curve was 0.689 (95% confidence interval: 0.570, 0.792, po0.01) at the cutoff
value of 86 U/L. Additionally, pleural adenosine deaminase had a sensitivity of 63.2% (46.0-78.2%); a specificity
of 73.7% (56.9-86.6%); positive and negative likelihood ratios of 2.18 and 0.50, respectively; and positive and
negative predictive values of 70.6% and 66.7%, respectively.
CONCLUSIONS: Pleural effusion adenosine deaminase is a helpful alternative biomarker for early and quick
discrimination of Gram-negative from Gram-positive bacterial infections of the pleural space, which is useful for
the selection of antibiotics.
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’ INTRODUCTION
Pleural infections, defined as parapneumonic effusion
(PPE) or empyema, are associated with considerable mor-
bidity, mortality and health care resource use (1-4). Recently,
the incidence of pleural infection has increased (5-6). In a
study of pleural infection in hospitalized adults that was
conducted in the United States, the frequency was 3.96 cases
per 100000 in 1996 and 8.10 cases per 100000 in 2008 (7). Delay
in the treatment of this type of infection may contribute to its
high mortality. Treating all patients who have suspected
pleural effusion (PE) with antibiotics while waiting for
microbiological results is not a good option because this
practice increases antibiotic resistance. Therefore, from the
standpoint of clinical utility, it is essential to develop a rapid
test differentiating Gram-negative from Gram-positive bacter-
ial infections of the pleural space.
Adenosine deaminase (ADA), an essential enzyme in purine
metabolism, catalyzes the hydrolytic deamination of adeno-
sine to form inosine (8). ADA is specifically secreted by
T lymphocytes and macrophages during infections and partici-
pates in cell-mediated immunity (9). This enzyme is present inDOI: 10.6061/clinics/2016(05)05
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most tissues as well as in the serum and is also secreted into
biological fluids during the cellular immune response against
intracellular pathogens, but its levels can also be increased in
other pathological processes (10-11). ADAwas reported to be a
useful biomarker in the diagnosis of tuberculous pleurisy and
has been characterized in many reports (12-15). In particular,
a meta-analysis showed that PE ADA had a sensitivity of
0.92 and a specificity of 0.90 in the diagnosis of tuberculous
pleurisy (16). PE ADA levels are usually higher in tuberculous
PE patients compared with other patients but may occasionally
be elevated in certain other cases. For example, more than
40% of parapneumonic patients and half of patients with
lymphomatous effusions exceed the cutoff set for pleural
tuberculosis (TB) (17). Pleural ADA levels are also elevated in
empyema, legionnaires’ disease, pleural brucellosis, lymphoma
and Mycoplasma pneumoniae pneumonia (17-20). Moreover,
various other factors are associated with pleural ADA, such as
age (21), pleural protein levels (22), smoking (23), polymorpho-
nuclear leukocyte counts (24), CD4+ cell numbers (25), and
sunitinib use (26).
Pleural ADA was also reported to be a predictor of the
outcomes of talc pleurodesis (27,28) and ulcerative colitis (29)
and to be a biomarker for the diagnosis of acute scrub typhus
(30) and pneumonia (31). In the present retrospective study,
we aimed to evaluate the diagnostic role of pleural ADA in
discrimination between Gram-negative and Gram-positive
bacterial infections of the pleural space.
’ MATERIALS AND METHODS
This was a retrospective observational study conducted from
June 2006 through May 2012 in the Department of Laboratory
Medicine, Shandong Provincial Chest Hospital. The study
was approved by the medical ethics committee of this hospital.
Written informed consent was not required because of the retro-
spective nature of the investigation. Patient records/information
were anonymized and de-identified prior to analysis.
Patients who met the following criteria were enrolled:
(1) pleural ADA had been assayed; (2) a positive PE culture
had been obtained, and a single bacterial strain had been
isolated; and (3) lymphoma and active TB were not present.
Measurements
Approximately 10 mL of PE sample was obtained with a
needle at the same time as thoracocentesis and was then sent
for ADA testing, biochemical testing and microbiological
culture. ADA activity was measured in the PE via a kinetic
method employing xanthine oxidase/peroxidase (32) and an
automated clinical chemistry analyzer using commercially
available kits (Maker, Sichuan, China). The intra-assay and
inter-assay coefficients of variability were p5% and p10%,
respectively. The cutoff value of ADA for TB diagnosis was
30 U/L. The levels of total protein (biuret method), total
bilirubin (vanadate oxidation method), glucose (hexokinase
method), lactate dehydrogenase (lactate-to-pyruvate method)
and amylase (CNPG3 method) in the PE were also assayed
using a chemistry analyzer.
Additionally, microbiological cultures and susceptibility
testing were performed using the Vitek (bioMerieux,
Hazelwood, MO, USA) system.
Statistical analysis
Statistical analysis was carried out using SPSS 17.0 software
and MedCalc Version 8.0.1.0. Continuous variables are given as
the mean±standard error of the mean (SEM). Non-parametric
tests were used because the ADA data had a skewed distri-
bution, as determined using the Kolmogorov-Smirnov test.
Differences in ADA levels between groups were analyzed
using the Mann-Whitney U test and correlations between ADA
and specified variables were quantified using Spearman’s
correlation coefficient.
Receiver operator characteristic (ROC) analysis was per-
formed to evaluate the ability of PE ADA to discriminate
between Gram-negative and Gram-positive bacterial infec-
tions of the pleural space. The cutoff point was determined
as the value of the parameter that maximized the sum of the
specificity and sensitivity. Positive and negative likelihood
ratios were also determined. A two-tailed p valueo0.05 was
considered statistically significant.
’ RESULTS
Study population
The baseline characteristics of the patients are shown in
Table 1. A total of 76 patients were enrolled into the study,
including patients with PPEs (n=35) and empyemas (n=41).
The patients then were grouped into the following sub-
groups: 1) patients with Gram-negative bacterial infections,
aged 53.2±18.6 years old, 81.6% (31/38) of whom were
male and 44.7% (17/38) had empyemas and 2) patients with
Gram-positive bacterial infections, aged 53.5±21.5 years old,
of whom 76.3% (29/38) were male and 63.1% (24/38) had
empyemas.
Description of pleural infections
Among the 76 cultures, 36 (47.4%) were positive for Gram-
positive cocci and 40 (52.6%) were positive for Gram-negative
bacteria. Enterococcus pneumoniae was the predominant Gram-
positive coccus and Pseudomonas pneumoniae was the predomi-
nant Gram-negative bacterium. Of all Staphylococcus isolates,
8 (66.7%) were methicillin-resistant Staphylococcus aureus (MRSA).
Moreover, 25% of Pseudomonas isolates were multi-drug
resistant organisms (MDROs), and 1 Escherichia isolate and
1 Klebsiella isolate were extended-spectrum b-lactamase (ESBL)
producers.
Levels of ADA and other biomarkers
Mean pleural ADA levels differed significantly between
Gram-negative and Gram-positive bacterial infections of the
pleural space (mean±SEM, 191.8±32.1 U/L vs 81.0±16.9 U/L,
po0.01) (Table 1). The levels of total protein, total bilirubin,
glucose, lactate dehydrogenase and amylase in the PE did not
differ significantly between the infection types (all p40.05).
There was a low negative correlation between pleural total
bilirubin and pleural ADA (r=-0.266, po0.05). There was also
Table 1 - Patient characteristics.
Gram-negative Gram-positive
Age 53.2±18.6 53.5±21.5
Sex (Male, %) 30/36 30/40
Total protein (g/L) 31.7±4.2 39.4±2.3
Total bilirubin (mol/L) 19.6±4.4 14.7±4.4
Glucose (mmol/L) 3.54±1.29 3.04±0.86
Lactate dehydrogenase (U/L) 359.5±58.9 289.3±42.0
ADA (U/L) 44.2±10.8 83.2±21.2
Amylase (U/L) 29.5±13.3 42.0±16.7
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a moderate negative correlation between ADA and glucose
(r=-0.357, po0.01). Meanwhile, a high positive correlation
was observed between ADA and lactate dehydrogenase in
the PE (r=0.769, po0.01).
Diagnostic performance of pleural ADA
To evaluate the diagnostic performance of pleural ADA,
ROC analysis was performed (Figure 1). The area under the
ROC curve was 0.689 (95% confidence interval (CI): 0.570,
0.792, po0.01) at the cutoff value of 86 U/L. Pleural ADA had a
sensitivity of 63.2% (95% CI: 46.0-78.2%); a specificity of 73.7%
(95% CI: 56.9-86.6%); positive and negative likelihood ratios of
2.18 and 0.50, respectively; and positive and negative predictive
values of 70.6% and 66.7%, respectively.
’ DISCUSSION
Rapid identification of the cause of pleural infection is
defined by microbiological culture and effective antimicro-
bial therapy after diagnosis could potentially improve the
outcome of pleural infection. However, in everyday clinical
practice, 12-24 hours are usually required to obtain a Gram
staining result once bacteria have been recovered from
pleural cultures. Thus, an alternative method is needed for
rapid diagnosis of the cause of PE. In the present study, we
evaluated PE ADA for the detection and differentiation of
Gram staining classification in pleural infection. In particular,
the optimal cutoff value of PE ADA activity for discriminat-
ing between Gram-negative and Gram-positive bacterial
infections of the pleural space was determined. The sensitivity
and specificity of PE ADAwere 63.2% and 73.7%, respectively.
This biomarker is thus a possible alternative to conventional
microbiological culture for discrimination of different types of
pleural infection.
Currently, only a few studies have focused on discrimina-
tion between Gram-negative and Gram-positive bacterial
infections. Charles PE et al. found that procalcitonin levels
were markedly higher in patients with Gram-negative
bacteremia than in those with Gram-positive bacteremia
(33). This finding implied a diagnostic application in differ-
entiating Gram-negative bacteremia from Gram-positive
bacteremia. However, the results of that retrospective study
could not be generalized to all patients with sepsis because
only those with bacteremia were included. In another study,
Xu XJ et al. (34) measured serum inflammatory cytokine
levels in patients with septic shock using flow cytometry.
The results showed that IL-6, IL-10, and TNF-a levels
were significantly higher in patients with Gram-negative
bacteremia than in those with Gram-positive bacteremia. Of
the three cytokines, IL-10 was the most useful biomarker for
Gram-negative bacteremia prediction in the derivation
cohort and a cutoff value of 50 pg/mL showed a sensitivity
of 70.8% and a specificity of 80.0%, with a positive predictive
value of 89.5%.
Carroll NM et al. (35) developed a nested PCR protocol for
detection of and discrimination between 14 species of Gram-
positive and Gram-negative bacteria in samples of ocular
fluids. In three culture-positive samples, complete concor-
dance was observed between the molecular methods and
culture results. PCR correctly identified the Gram staining
classification of the organisms; however, high rates of false-
positive nested PCR affected interpretation of the observed
sensitivity of the test. Chan KY et al. (36) showed that the
Gram-specific q-PCR test was highly specific and provided
very good positive and negative predictive values for
differentiating Gram-negative and Gram-positive systemic
bacterial infections at the onset of clinical presentation in
preterm infants. If the q-PCR test was positive, the chance of
a true infection being present was 97.2%. However, only
common Gram-negative and Gram-positive organisms were
included in the genetic sequences of the primer/probes,
so certain organisms could escape detection. The Hyplex
BloodScreen PCR-ELISA system was also evaluated for
direct identification of pathogenic bacteria in a large panel
of positive BACTEC 9240 blood culture bottles (37). In
contrast to conventional culture and biochemical identifica-
tion techniques, which usually take 1-2 days, the Hyplex
BloodScreen PCR-ELISA system generated results much
more quickly. This method had a very high sensitivity,
ranging from 96.6-100% for detecting various organisms. The
specificity was also high, exceeding 97.5% for Escherichia coli.
However, this method also requires microbiological culture.
Our current study differed from these previous studies in
that ADA testing is routinely performed in clinical settings
as a time-saving test. Although the diagnostic value of PE
ADA was limited in discrimination between Gram-negative
and Gram-positive bacterial infections of the pleural space,
ADA measurement is available sooner than Gram staining
results are and may possibly be an alternative to conven-
tional microbiological culture for discrimination of pleural
infections. The difference between pleural Gram-negative
and Gram-positive bacterial infections in terms of the levels
of PE ADA is related to immune responses upon stimulation
with Gram-positive and Gram-negative bacteria, which
may contribute to the role of ADA in lipopolysaccharide
(LPS)-induced inflammatory responses. A previous study
showed that IL-6, IL-10 and TNF-a levels were significantly
higher in patients with Gram-negative bacteremia than in
Figure 1 - Receiver operator characteristic curve for pleural
effusion adenosine deaminase to discriminate between Gram-
negative and Gram-positive bacterial infections of the pleural
space. The area under the curve was 0.689 (95% CI: 0.570, 0.792,
po0.01).
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those with Gram-positive bacteremia (34). A recent study also
found that inhibition of ADA attenuated the effect of LPS-
induced inflammatory responses, such as by decreasing the
levels of serum TNF-a, IL-1b, and IL-10. The results indicated
that lowering ADA activity may be a novel and viable
therapeutic approach to managing Gram-negative bacterial
infection (38). In our study, the PE ADA level was lower in
patients with Gram-negative bacterial infection compared with
those with Gram-positive bacterial infection. This low ADA
activity may be a protective factor against Gram-negative
bacterial infection of the pleural space.
One of the limitations in this study was that no infor-
mation was provided about the pleural cytology. In the
study, approximately 60% of patients presented cell lysis
during cytologic examination, and it has been reported that
approximately 84% of purulent fluids contain lysed leuko-
cytes (39). Previous studies have demonstrated a correlation
between the pleural ADA level and CD4+ lymphocyte counts
(40), suggesting that pleural cytology may have the ability to
discriminate between pleural infections. Another limitation of
the current study was its retrospective, non-randomized nature,
but selection bias was likely limited because all patients with
suspected pleural infection at our hospital undergo pleural
culture and PE biochemical tests. When interpreting the results,
the sample size and medium performance (sensitivity and
specificity) should also be considered.
In conclusion, the levels of PE ADA in pleural infections
caused by Gram-positive bacteria were high compared with
the levels in pleural infections caused by Gram-negative
bacteria. Subsequent analysis showed that PE ADA was a
helpful alternative approach for early and quick discrimina-
tion of Gram-negative from Gram-positive bacterial infec-
tions of the pleural space, which would be useful for
the selection of antibiotics. Because ADA measurement is
available sooner than Gram staining results are, the former
may possibly be an alternative to conventional microbiolo-
gical culture for discrimination of pleural infections, parti-
cularly because drug susceptibility testing of clinical isolates
has shown that antimicrobial resistance has become a serious
concern in the treatment of pleural infection.
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